Letter to Editor
Mahdi Bozorgnia*, Keihan Zoughalchi and Shahriar Gharibzadeh
Dear Editor, In December of 2019, a novel coronavirus (SARS-CoV-2) crossed species barriers to infect humans and was effectively transmitted from person to person, leading to a pneumonia outbreak first reported in Wuhan, China [1]. The most common symptoms at on set of COVID-19 illness are fever, cough, and fatigue, while other symptoms include sputum production, headache, haemoptysis, diarrhoea, dyspnoea, and lymphopenia [2].
Research Article
Hernandez-Matias L, Maysonet-Cruz J, Calzada-Jorge N, Pérez-Donato L, Torres Rivera W, Ramírez-Rodríguez J, Laureano-Torres F, Méndez LB, Ríos O, Menéndez-Pérez J, Washington AV* and Hunter-Mellado R
Essential Thrombocythemia (ET) is characterized by a persistent thrombocytosis associated with mutations in Janus Kinase 2 (JAK2V617F), Myeloproliferative Leukemia protein (MPL), and/ or Calreticulin (CALR). Although ET mutational background has been defined for some
Research Article
Richardson MW*, Olivares MM and Visintainer PF
Background: To determine if c-reactive protein (crp) can predict possible bacterial infections in children with sickle cell disease (SCD) and fever who are admitted to the hospital.
